- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Exploring Post-Traumatic Stress Disorder: Pathophysiology

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Exploring Post-Traumatic Stress Disorder: Pathophysiology
Although there may be many etiologies, Post-Traumatic Stress Disorder (PTSD) is a dynamic disorder that involves fluctuations between contrasting forms of emotional dysregulation.1 This webinar will provide a high-level overview of the pathophysiology of PTSD, including discussion of the potential role of monoamine neurotransmitter systems involved in emotional regulation and fear response in the amygdala.
References:
1. Yehuda R, et al. Nat Rev Dis Primers. 2015;1:15057.

Steven Stoner, PharmD
Associate Dean for Student Affairs/Clinical Professor, University of Missouri-Kansas City School of Pharmacy
More

Miranda Fisher, PhD
Medical Science Liaison
Speaker Steven Stoner, PharmD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Miranda Fisher, Phd. is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)